Dataset Information

Birthing parents had a lower risk of testing positive for SARS-CoV-2 in the peripartum period in Norway, 15^th of February 2020 to 15^th of May 2021.

ABSTRACT: Hospital infection control measures against COVID-19 may come into conflict with patients' need for support. In Norway, some hospitals have restricted access for partners of women giving birth. We investigated the incidence rate of SARS-CoV-2 among birthing parents compared to similarly aged women and men in the general population; and the additional risk posed by allowing partners in. Birthing parents often shared infection status and had a slightly lower incidence rate than the general population in the peripartum period. They should not be considered a high-risk group for SARS-CoV-2 infections.

SUBMITTER: Danielsen AS

PROVIDER: S-EPMC8579713 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Birthing parents had a lower risk of testing positive for SARS-CoV-2 in the peripartum period in Norway, 15<sup>th</sup> of February 2020 to 15<sup>th</sup> of May 2021.

Danielsen Anders Skyrud AS Cyr Pascale-Renée PR Magnus Maria Christine MC Gravningen Kirsten Midttun KM Eriksen-Volle Hanne-Merete HM Kacelnik Oliver O

Infection prevention in practice 20211110 4

Hospital infection control measures against COVID-19 may come into conflict with patients' need for support. In Norway, some hospitals have restricted access for partners of women giving birth. We investigated the incidence rate of SARS-CoV-2 among birthing parents compared to similarly aged women and men in the general population; and the additional risk posed by allowing partners in. Birthing parents often shared infection status and had a slightly lower incidence rate than the general populat ...[more]

PMID: 34786552

Similar Datasets

Project description:The 2020-2021 epidemic with a total of 3,555 reported HPAI detections and around 22,400,000 affected poultry birds in 28 European Countries appears to be one of the largest and most devastating HPAI epidemics ever occurred in Europe. Between 24 February and 14 May 2021, 1,672 highly pathogenic avian influenza (HPAI) virus detections were reported in 24 EU/EEA countries and the UK in poultry (n=580), and in wild (n=1,051) and captive birds (n=41). The majority of the detections in poultry were reported by Poland that accounted for 297 outbreaks occurring in a densely populated poultry area over a short period of time, followed by Germany with 168 outbreaks. Germany accounted for 603 detections in wild birds, followed by Denmark and Poland with 167 and 56 detections, respectively. A second peak of HPAI-associated wild bird mortality was observed from February to April 2021 in north-west Europe. The observed longer persistence of HPAI in wild birds compared to previous years may result in a continuation of the risk for juveniles of wild birds and mammals, as well as for virus entry into poultry farms. Therefore, enhanced awareness among farmers to continue applying stringent biosecurity measures and to monitor and report increases in daily mortality and drops in production parameters, are recommended. Sixteen different genotypes were identified to date in Europe and Russia, suggesting a high propensity of these viruses to reassort. The viruses characterized to date retain a preference for avian-type receptors; however, transmission events to mammals and the identification of sporadic mutations of mammal adaptation, indicate ongoing evolution processes and possible increased ability of viruses within this clade to further adapt and transmit to mammals including humans. Since the last report, two human infections due to A(H5N6) HPAI were reported from China and Laos and 10 human cases due to A(H9N2) low pathogenic avian influenza (LPAI) virus identified in China and Cambodia. The risk of infection for the general population in the EU/EEA is assessed as very low and for occupationally exposed people low. People exposed during avian influenza outbreaks should adhere to protection measures, strictly wear personal protective equipment and get tested immediately when developing respiratory symptoms or conjunctivitis within 10 days after exposure.

Dataset Information

Birthing parents had a lower risk of testing positive for SARS-CoV-2 in the peripartum period in Norway, 15^th of February 2020 to 15^th of May 2021.

Publications

Birthing parents had a lower risk of testing positive for SARS-CoV-2 in the peripartum period in Norway, 15<sup>th</sup> of February 2020 to 15<sup>th</sup> of May 2021.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Dataset Information

Birthing parents had a lower risk of testing positive for SARS-CoV-2 in the peripartum period in Norway, 15th of February 2020 to 15th of May 2021.

Publications

Birthing parents had a lower risk of testing positive for SARS-CoV-2 in the peripartum period in Norway, 15<sup>th</sup> of February 2020 to 15<sup>th</sup> of May 2021.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Birthing parents had a lower risk of testing positive for SARS-CoV-2 in the peripartum period in Norway, 15^th of February 2020 to 15^th of May 2021.